Swiss surgeons have significantly improved mechanical removal of blood clots in stroke patients by intra-arterial administration of the thromolytic urokinase.
At the 15th Annual Scrip Awards, Mogrify Chair Jane Osbourn has been presented with the Lifetime Achievement Award. She received the award in recognition of her outstanding contribution to the biotech industry throughout her career.
/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png00h.genrich/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngh.genrich2019-12-05 07:50:002019-12-05 07:50:00Roche Diagnostics: Up the ladder
T cell agonist specialist ImCheck Therapeutics will use €48m (US$53m) from a Series B financing to push clincial pipeline of antibodies activating gamma-delta T-cells.
Pierre Fabre SA and Puma Biotechnology, Inc. have broadened the geographic coverage of their license agreement on commercialisation of Nerlynx® (neratinib).
The European Commission and the European Investment Bank (EIB) have selected ECBF Management GmbH as investment advisor for the €250m EU circular bioeconomy fund.
https://european-biotechnology.com/wp-content/uploads/2024/04/european-investment-bank.jpg499750Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2019-12-02 09:02:072019-12-02 09:02:07European circular bioeconomy fund near closing
https://european-biotechnology.com/wp-content/uploads/2024/04/Bildschirmfoto_2019-11-29_um_08.03.09.png305550Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2019-11-29 19:41:002019-11-29 19:41:00Researchers find new indication for cancer drug
Urokinase clears blot clots in stroke patients
Latest NewsSwiss surgeons have significantly improved mechanical removal of blood clots in stroke patients by intra-arterial administration of the thromolytic urokinase.
Mogrify: Decorated chair
AppointmentsAt the 15th Annual Scrip Awards, Mogrify Chair Jane Osbourn has been presented with the Lifetime Achievement Award. She received the award in recognition of her outstanding contribution to the biotech industry throughout her career.
Sanofi buys Synthorx Inc for US$2.35bn
Latest NewsSanofi will acquire Synthorx Inc to expand its immuno-oncology pipeline with THOR-707, an optimised IL-2 candidate.
Meatable NV raises US$10m in seed funding
Latest NewsMeatable NV, a specialist for cultivated meat, has raised an additional US$10m in seed funding, bringing the company’s total funding to US$13m.
Roche Diagnostics: Up the ladder
AppointmentsClaus Haberda will be the new Managing Director at Roche Diagnostics GmbH, succeeding Ursula Redeker, who will return to Basel.
Big Pharma is cost driver of GAVI
Latest NewsMédecins Sans Frontières (MSF) called on the GAVI Vaccine Alliance not to pay huge subsidies to Big Pharma companies for pneumococcal vaccine
ImCheck Therapeutics SAS raises €48m
Latest NewsT cell agonist specialist ImCheck Therapeutics will use €48m (US$53m) from a Series B financing to push clincial pipeline of antibodies activating gamma-delta T-cells.
Pierre Fabre amends license agreement with Puma Biotechnology
Latest NewsPierre Fabre SA and Puma Biotechnology, Inc. have broadened the geographic coverage of their license agreement on commercialisation of Nerlynx® (neratinib).
European circular bioeconomy fund near closing
Latest NewsThe European Commission and the European Investment Bank (EIB) have selected ECBF Management GmbH as investment advisor for the €250m EU circular bioeconomy fund.
Researchers find new indication for cancer drug
Latest NewsFrench researchers have found MALT1 blockers not only to act on blood cancers but also to be effective as a treatment for glioblastoma.